LYFE Sciences · Project HERA
Variant Interpretation · Classification Report
Generated: 2026-11-19
Case ID: NM_001904.4_c.59C_T_20261119_203400
Framework: ACMG/AMP 2015
Variant classification summary

NM_001904.4:c.59C>T

CTNNB1  · NP_001895.1:p.(Ala20Val)  · NM_001904.4
GRCh37: chr3:41266062 C>T  ·  GRCh38: chr3:41224571 C>T
Gene: CTNNB1 Transcript: NM_001904.4
Final call
Likely Benign
PM2 moderate BP4 supporting BP5 supporting
All criteria require review: For research and educational purposes only.
Gene
CTNNB1
Transcript
NM_001904.4
Protein
NP_001895.1:p.(Ala20Val)
gnomAD AF
2.4787724127503096e-06 (v4.1)
ClinVar
Uncertain significance
OncoKB
Unknown Oncogenic Effect
Interpretation summary
Generated evidence synthesis
1
Likely Benign: PM2 moderate is insufficient by itself to satisfy a generic pathogenic combination.
2
Likely Benign: BP4 supporting is met by REVEL 0.085, below the 0.29 benign-prediction threshold.
3
Likely Benign: BP5 supporting is met because the tumor also carried several inactivating APC mutations.
Final determination: Under the generic ACMG/AMP 2015 fallback, two Supporting benign criteria (BP4 and BP5) yield Likely Benign, while PM2 Moderate does not independently satisfy a pathogenic rule.
ACMG/AMP criteria review
Criteria shown when status is available
All criteria require review: For research and educational purposes only.
Criterion Status Rationale Evidence used
PVS1 N/A Not applicable: PVS1 requires a null variant (nonsense, frameshift, canonical splice, start-loss or stop-loss), and this is a missense variant.
pvs1_generic_framework generic_acmg_combination_rules
PS1 Not met Not met: p.Ala20Val is classified as uncertain significance in ClinVar, and available tumor reports do not establish a pathogenic germline amino-acid change.
clinvar PMID:33535453
PS2 Not assessed Not assessed: no report documents confirmed maternity and paternity, a de novo germline event, and absence of family history for this variant.
PMID:21901162 PMID:39202333
PS3 Not met Not met: available evidence is computational or tumor-observational, with no validated in vitro or in vivo assay demonstrating a damaging effect for p.Ala20Val.
PMID:39202333 PMID:32365560 PMID:33535453 PMID:21901162
PS4 Not assessed Not assessed: exact-variant reports provide somatic tumor observations but no affected-versus-control counts or odds ratio with confidence interval.
PMID:21901162 PMID:33535453 PMID:39202333
PM1 Not met Not met: residue 20 is reported outside critical CTNNB1 sites, and Cancer Hotspots found no statistically significant hotspot.
PMID:21901162 PMID:39202333 hotspots
PM2 Met Met at Moderate: gnomAD v4.1 all-comers AF is 2.47877e-06 from 4/1,613,702 alleles, below the 0.0001 PM2 cutoff, with zero homozygotes.
gnomad_v4 gnomad_v2 PMID:25741868
PM3 N/A Not applicable: CTNNB1-related disease is autosomal dominant in this case, whereas PM3 is restricted to recessive disorders with a pathogenic variant confirmed in trans.
PMID:21901162 PMID:33535453
PM4 N/A Not applicable: PM4 requires a protein-length change, and this is a missense variant.
pvs1_generic_framework generic_acmg_combination_rules
PM5 Not met Not met: p.Ala20Thr is a same-residue comparator, but the report does not establish it as pathogenic under ACMG/AMP.
PMID:32365560 PMID:21901162
PM6 Not assessed Not assessed: no proband-level report describes this variant as assumed de novo without confirmed parental testing.
PMID:21901162 PMID:39202333
PP1 Not assessed Not assessed: zero documented affected relatives with genotype and phenotype data are available for segregation analysis.
PMID:21901162 PMID:39202333
PP2 Not assessed Not assessed: no supplied gene-wide evidence establishes both low benign missense variation and missense as a common CTNNB1 disease mechanism.
PP3 Not met Not met: REVEL 0.085 is below the >=0.644 PP3 supporting threshold for this missense variant.
revel
PP4 Not assessed Not assessed: available reports describe somatic tumors, including one with inactivating APC mutations, not a highly specific germline CTNNB1 phenotype.
PMID:21901162 PMID:32365560 PMID:33535453
PP5 Not met Not met: ClinVar shows two ordinary laboratory Uncertain-significance submissions and zero expert-panel classifications for the exact variant.
clinvar
BA1 Not assessed Not assessed: gnomAD v4.1 total AF is 2.47877e-06, but the required grpmax FAF is unavailable and cannot be replaced by a popmax point estimate.
gnomad_v4 clinvar PMID:25741868
BS1 Not assessed Not assessed: gnomAD v4.1 total AF is 2.47877e-06, but grpmax FAF is unavailable and no disorder-specific maximum credible frequency calculation is provided.
gnomad_v4
BS2 Not assessed Not assessed: gnomAD reports zero homozygotes but does not document a specific healthy adult carrier with genotype, age, and phenotype.
gnomad_v2 gnomad_v4 PMID:25741868
BS3 Not met Not met: no validated in vitro or in vivo assay shows that CTNNB1 p.Ala20Val has no damaging effect on protein function or splicing.
PMID:39202333 PMID:32365560 PMID:33535453 PMID:21901162
BS4 Not assessed Not assessed: no affected relatives have documented genotype and phenotype results showing that the variant fails to segregate.
PMID:21901162 PMID:39202333
BP1 Not assessed Not assessed: supplied extracts show both truncating and missense CTNNB1 disease observations but do not establish that disease is primarily truncating.
BP2 Not assessed Not assessed: no germline paired pathogenic variant or phase result is reported, so neither the BP2 trans nor cis condition can be evaluated.
PMID:21901162 PMID:33535453
BP3 N/A Not applicable: BP3 requires an in-frame indel in a repeat region, and this is a missense variant.
pvs1_generic_framework generic_acmg_combination_rules
BP4 Met Met, supporting: REVEL 0.085 is below the <=0.29 BP4 threshold for this missense variant.
revel
BP5 Met Met, Supporting: the exact p.A20V colorectal tumor also carried several inactivating APC mutations, an alternate molecular basis for disease.
PMID:21901162
BP6 Not met Not met: no qualifying reputable benign report is available; ClinVar contains only two ordinary laboratory Uncertain-significance submissions and no expert-panel submission.
clinvar
BP7 N/A Not applicable: BP7 requires a synonymous variant, and this is a missense variant.
generic_acmg_combination_rules
Disclaimer: The content and results provided by LYFE Sciences are for research and educational purposes only and must not be used as a substitute for professional medical judgment, diagnosis, or treatment. Always consult a qualified healthcare professional before making any clinical decisions.